FEMY.NASDAQFemasys INC

Form 4: Femasys CFO Elefant Acquires Convertible Notes, Warrants

Sentiment:

Insider Transaction Report


Femasys CFO Dov Elefant has acquired senior secured convertible notes and three series of warrants, representing a direct investment in the company.

Capital raiseThe reporting person purchased Senior Secured Convertible Notes and three series of warrants for an aggregate amount of $25,000, which represents an investment into the company.
Better than expectedA key executive (CFO) making a direct personal investment in the company's securities is generally viewed as a positive signal of confidence in the company's future performance.The investment involves long-term derivative instruments (notes and warrants expiring in 2035), indicating a belief in sustained long-term growth and value creation.

Summary

  • Dov Elefant, Chief Financial Officer of Femasys Inc. (FEMY), acquired derivative securities.
  • The acquisition includes Senior Secured Convertible Notes due 2035 and three series of warrants: Series A-1, Series B-1, and Series C-1.
  • The aggregate purchase amount for all reported securities was $25,000.
  • The Senior Secured Convertible Notes have an initial conversion price of $0.73 per share and can be converted into a maximum of 34,122 shares of common stock from the original stated amount.
  • The Series A-1 Warrants have an initial exercise price of $0.81 per share, Series B-1 Warrants at $0.92 per share, and Series C-1 Warrants at $1.10 per share.
  • Each series of warrants is exercisable into 34,122 shares of common stock.
  • All derivative securities become exercisable/convertible on November 7, 2025, and expire on November 7, 2035.
  • Conversion and exercise are subject to certain limitations in accordance with Nasdaq Capital Market rules.

Sentiment

Score: 8

Explanation: The direct investment by the CFO, particularly in long-term derivative securities, indicates strong insider confidence in the company's future. This is generally viewed very positively by the market.

Positives

  • Direct investment by a key executive (CFO) signals confidence in the company's future prospects.
  • The acquisition of convertible notes and warrants provides capital to the company, with an aggregate purchase amount of $25,000.
  • The long-term nature of the derivatives (expiring 2035) suggests a long-term commitment from the CFO.

Risks

  • Conversion of notes and exercise of warrants are subject to certain limitations in accordance with Nasdaq Capital Market rules, which could affect the holder's ability to fully realize the underlying shares.
  • The value of the investment is dependent on the future stock price of Femasys Inc. exceeding the conversion and exercise prices.

Future Outlook

The acquisition of long-dated convertible notes and warrants by the CFO suggests an expectation of future stock price appreciation for Femasys Inc. over the next decade, as the derivatives are profitable only if the stock price rises above their respective conversion/exercise prices.

Management Comments

  • The reported securities were purchased by the reporting person for an aggregate amount of $25,000.

Industry Context

This insider investment by the CFO of Femasys Inc. is a common signal of management confidence, particularly in growth-oriented or smaller-cap companies where such direct investments can be seen as a strong endorsement of future prospects, potentially attracting further investor interest.

Related Party Transactions

  • Dov Elefant, the Chief Financial Officer, acquired derivative securities from Femasys Inc., constituting a transaction between a company executive and the company.

Stakeholder Impact

  • Shareholders: May view the CFO's investment as a positive signal of confidence, potentially leading to increased investor interest and share price appreciation.
  • Company: Receives $25,000 in capital from the transaction.

Next Steps

  • The reporting person may convert the Senior Secured Convertible Notes into common stock at an initial price of $0.73 per share, subject to limitations.
  • The reporting person may exercise the Series A-1, B-1, and C-1 Warrants into common stock at their respective exercise prices ($0.81, $0.92, $1.10), subject to limitations.

Key Dates

DateDescription
11/07/2025Transaction date for acquisition of Senior Secured Convertible Notes, Series A-1 Warrants, Series B-1 Warrants, and Series C-1 Warrants. Also the date these derivatives become exercisable/convertible.
11/07/2035Expiration date for Senior Secured Convertible Notes, Series A-1 Warrants, Series B-1 Warrants, and Series C-1 Warrants.
11/12/2025Signature date of the reporting person's attorney-in-fact for the filing.

Recommendation

buy

The direct investment by the Chief Financial Officer, Dov Elefant, through the purchase of long-term convertible notes and warrants, signals strong insider confidence in Femasys Inc.'s future prospects. Such an investment, especially by a key executive with deep knowledge of the company's financials and strategy, often precedes positive operational developments or indicates a belief that the current stock price is undervalued relative to future potential. The long-dated nature of these derivatives further underscores a long-term bullish outlook. This insider buying activity provides a compelling reason for investors to consider a 'buy' recommendation, aligning with management's demonstrated belief in the company's value.

Keywords

Femasys Inc., FEMY, Dov Elefant, CFO, Insider Trading, Form 4, Convertible Notes, Warrants, Equity Investment, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.